Developing a standard approach to immune checkpoint inhibitor toxicity management in Ontario.

被引：0
|
作者：
Crespo, Andrea
Abella, Lourdes
Baetz, Tara D.
Gallo-Hershberg, Daniela
Lakhani, Nita
Leighl, Natasha B.
Pasetka, Mark
Seymour, Lesley
Vu, Kathy
Forbes, Leta Marie
机构：
[1] Canc Care Ontario, Toronto, ON, Canada
[2] Canc Ctr Southeastern Ontario, Kingston, ON, Canada
[3] Princess Margaret Canc Ctr, Toronto, ON, Canada
[4] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 30期
关键词：
D O I：
10.1200/JCO.2018.36.30_suppl.255
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
255
引用
收藏
页数：2
相关论文
共 50 条
  • [21] At the Heart of Immune checkpoint Inhibitor-Induced Immune Toxicity
    Young, Arabella
    Bluestone, Jeffrey A.
    CANCER DISCOVERY, 2021, 11 (03) : 537 - 539
  • [22] Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case series
    Harvey, Catriona
    Nahar, Kazi J.
    Mckeown, Janet
    Lo, Serigne N.
    Farag, Sheima
    Yousaf, Nadia
    Young, Kate
    Tas, Liselotte
    Meerveld-Eggink, Aafke
    Blank, Christian
    Thomas, Austin
    Mcquade, Jennifer
    Schilling, Bastian
    Johnson, Douglas B.
    Huertas, Roberto Martin
    Arance, Ana
    Lee, Joanna
    Zimmer, Lisa
    Long, Georgina, V
    Carlino, Matteo S.
    Wang, Yinghong
    Menzies, Alexander Maxwell
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (01)
  • [23] A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy
    Kottschade, Lisa
    Brys, Adam
    Peikert, Tobias
    Ryder, Mabel
    Raffals, Laura
    Brewer, Jerry
    Mosca, Paul
    Markovic, Svetomir
    MELANOMA RESEARCH, 2016, 26 (05) : 469 - 480
  • [24] Management of Immune Checkpoint Inhibitor Mediated Myocarditis
    Mudra, Sarah
    Culver, Austin
    Kumar, Ashwin
    Yesilyaprak, Abdullah
    Agrawal, Ankit
    Dey, Amit K.
    Rizk, Alexander
    Li, Jason
    Johnson, Adam
    McGowan, Kevin
    Majid, Muhammad
    Njus, Meredith
    Lawrence, Luke
    Klein, Allan L.
    CIRCULATION, 2023, 148
  • [25] Immunity and immune toxicity: clinical management of immune checkpoint inhibition
    Keilholz, U.
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 : 21 - 21
  • [26] Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review
    Sise, Meghan E.
    Seethapathy, Harish
    Reynolds, Kerry L.
    ONCOLOGIST, 2019, 24 (06): : 735 - 742
  • [27] Management of infliximab-refractory immune checkpoint inhibitor gastrointestinal toxicity: A multicenter case series
    Harvey, Catriona
    Nahar, Kazi Jannatun
    Lo, Serigne N.
    Ahmed, Tasnia
    Farag, Sheima
    Yousaf, Nadia
    Young, Kate
    Tas, Liselotte
    Meerveld-Eggink, Aafke
    Blank, Christian U.
    Thomas, Austin
    McQuade, Jennifer Leigh
    Schilling, Bastian
    Johnson, Douglas Buckner
    Huertas, Roberto Martin
    Arance, Ana Maria
    Lee, Joanna
    Zimmer, Lisa
    Long, Georgina V.
    Menzies, Alexander M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [28] GRAVE CONSEQUENCES OF IMMUNE CHECKPOINT INHIBITOR TOXICITY BEYOND MYOCARDITIS
    Trivedi, Rishi
    Tacon, Phillip
    Aiken, Achilles V.
    Chyu, Kuang-Yuh
    Ebinger, Joseph
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3470 - 3470
  • [29] Immune Checkpoint Inhibitor Toxicity Review for the Palliative Care Clinician
    Hansen, Eric D.
    Wang, Xiao
    Case, Amy A.
    Puzanov, Igor
    Smith, Tom
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2018, 56 (03) : 460 - 472
  • [30] Immune checkpoint inhibitor and encephalic radiotherapy: Toxicity and Adverse events
    Matteucci, P.
    Santo, B.
    Ippolito, E.
    Zuccoli, P.
    Petrianni, G. M.
    Trecca, P.
    Gentile, S.
    Miele, M.
    Palizzi, S.
    Trodella, L.
    D'Angelillo, R. M.
    Ramella, S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S678 - S678
12345